The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing consistent efficacy across diverse patient subgroups. Patients with lower tumor ...

Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Please provide your email address to receive an email when new articles are posted on . The regional treatment conferred a significantly higher overall response rate than best alternative care. Median ...

Here is a breakdown of some of the important information surrounding uveal melanoma, an extremely rare form of cancer. Uveal melanoma is a rare form of eye cancer that many patients may not be aware ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to IOA-244 for the treatment of uveal melanoma, according to a press ...

Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) is a rare paraneoplastic syndrome in which diffuse proliferation of melanocytes within the uveal tract leads to significant ocular morbidity.

Tebentafusp, a T-cell receptor–bispecific molecule that targets glycoprotein 100 and CD3, is approved for adult patients who are positive for HLA-A*02:01 and have unresectable or metastatic uveal ...

GENEVA--(BUSINESS WIRE)--iOnctura SA, a clinical-stage oncology company targeting key resistance mechanisms in solid tumors, announced today that it will present Phase Ib data on its lead pipeline ...

An international, open-label trial demonstrated the overall survival benefits of administering tebentafusp to HLA-A*02:01-positive patients with metastatic uveal melanoma. A recent phase 3 trial ...

(RTTNews) - IDEAYA Biosciences, Inc. (IDYA) has announced the completion of targeted full enrolment of 435 patients in its OptimuUM-02 Phase 2/3 trial, evaluating Darovasertib in combination with ...

Servier and IDEAYA Biosciences (IDYA) enter into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US Darovasertib is a small molecule developed for ...